1057 related articles for article (PubMed ID: 16769655)
1. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
2. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
[TBL] [Abstract][Full Text] [Related]
3. Immunoserological aspects of idiopathic inflammatory muscle disease.
Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T
Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964
[TBL] [Abstract][Full Text] [Related]
4. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
Rönnelid J; Barbasso Helmers S; Storfors H; Grip K; Rönnblom L; Franck-Larsson K; Nordmark G; Lundberg IE
Autoimmun Rev; 2009 Sep; 9(1):58-61. PubMed ID: 19285154
[TBL] [Abstract][Full Text] [Related]
5. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
[TBL] [Abstract][Full Text] [Related]
6. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
Selva-O'Callaghan A; Labrador-Horrillo M; Solans-Laque R; Simeon-Aznar CP; Martínez-Gómez X; Vilardell-Tarrés M
Arthritis Rheum; 2006 Oct; 55(5):791-8. PubMed ID: 17013837
[TBL] [Abstract][Full Text] [Related]
7. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features and misdiagnosis of anti-Jo-1 syndrome: analysis of 33 cases].
Zheng WJ; Wei W; Tang FL
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1565-8. PubMed ID: 14642109
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
Koenig M; Fritzler MJ; Targoff IN; Troyanov Y; Senécal JL
Arthritis Res Ther; 2007; 9(4):R78. PubMed ID: 17688695
[TBL] [Abstract][Full Text] [Related]
10. Immune manifestations of inflammatory muscle disease.
Targoff IN
Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326
[TBL] [Abstract][Full Text] [Related]
11. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
Yoshifuji H; Fujii T; Kobayashi S; Imura Y; Fujita Y; Kawabata D; Usui T; Tanaka M; Nagai S; Umehara H; Mimori T
Autoimmunity; 2006 May; 39(3):233-41. PubMed ID: 16769657
[TBL] [Abstract][Full Text] [Related]
12. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease.
La Corte R; Lo Mo Naco A; Locaputo A; Dolzani F; Trotta F
Autoimmunity; 2006 May; 39(3):249-53. PubMed ID: 16769659
[TBL] [Abstract][Full Text] [Related]
13. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy.
Chinoy H; Payne D; Poulton KV; Fertig N; Betteridge Z; Gunawardena H; Davidson JE; Oddis CV; McHugh NJ; Wedderburn LR; Ollier WE; Cooper RG;
Rheumatology (Oxford); 2009 Oct; 48(10):1213-7. PubMed ID: 19690132
[TBL] [Abstract][Full Text] [Related]
14. [Myositis, polysynovitis and pulmonary fibrosis: anti-Jo-1 syndrome].
Perrenoud FG; Van Lindhoudt D; Ochsner F; Janzer RC; Ott H
Schweiz Med Wochenschr; 1996 Jan; 126(4):120-3. PubMed ID: 8578293
[TBL] [Abstract][Full Text] [Related]
15. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.
Schnitz W; Taylor-Albert E; Targoff IN; Reichlin M; Scofield RH
J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies.
Sato S; Kuwana M; Hirakata M
Rheumatology (Oxford); 2007 May; 46(5):842-5. PubMed ID: 17255133
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF).
Mejía M; Herrera-Bringas D; Pérez-Román DI; Rivero H; Mateos-Toledo H; Castorena-García P; Figueroa JE; Rojas-Serrano J
Respir Med; 2017 Feb; 123():79-86. PubMed ID: 28137500
[TBL] [Abstract][Full Text] [Related]
19. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
[TBL] [Abstract][Full Text] [Related]
20. The type I interferon system in idiopathic inflammatory myopathies.
Lundberg IE; Helmers SB
Autoimmunity; 2010 Apr; 43(3):239-43. PubMed ID: 20187702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
